How can antiretroviral therapy be kept affordable without compromising the quality of care? While the Netherlands has a very different health care system than the one in the United States — including universal health insurance and government price controls—the country’s innovative approaches to cost management offer valuable insights for U.S. health care providers grappling with similar challenges.
TheBodyPro spoke with Piter Oosterhof, Pharm.D., a hospital pharmacist at OLVG in Amsterdam and Ph.D. candidate at Radboud University in the Netherlands whose thesis focuses on tackling financial challenges in HIV care. His research has investigated the use of generic medications, the strategic “de-simplification” of single-tablet regimens, and how shared decision-making with patients can contribute to cost efficiency while maintaining treatment effectiveness.
Read the full interview by Roger Pebody here.
Source : TheBodyPro
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.